Nasdaq: STLN, STLNW
Starling Oncology insiders
The officers, directors and 10% owners of Starling Oncology, Inc. who hold the most stock, valued at the live STLN price.
$3.18
STLN today −$20K (−0.63%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 6
- Their STLN stock
- $104M
- Market value
- $324M
- Held by ranked insiders
- 32.2%
Insiders by value of STLN holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Richard Barasch | Director | 11,825,841 | $37.6M | 11.6% | 2953rd |
| 2 | Jorey Chernett | 10% owner | 7,858,091 | $25.0M | 7.70% | 2608th |
| 3 | Richy Agajanian | 10% owner | 6,549,124 | $20.8M | 6.42% | 5028th |
| 4 | Ravi Yang Sarin | Director | 4,185,198 | $13.3M | 4.10% | 7077th |
| 5 | Daniel Virnich | Chief Executive Officer | 2,332,064 | $7.4M | 2.29% | 10935th |
| 6 | Mark Stolper | Director | 56,957 | $181K | <0.1% | 9776th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Starling Oncology; see each profile for the filing.